Differential hepatic lobar gene expression in offspring exposed to altered maternal dietary protein intake.

Increased plasma fibrinogen concentrations are a recognized risk factor for coronary heart disease, and increased fibrinogen levels in adults are associated with parameters of reduced early growth. We studied fibrinogen gene expression in adult offspring of dams fed either a 20% (control) or an 8% protein diet [maternal low-protein (MLP) rats] during pregnancy and lactation and determined whether any effects were consistent between left and right liver lobes, since the fetal liver has a unique blood supply that produces differential stimuli to the left and right lobes. In MLP offspring, there was a reduction in all three fibrinogen mRNA copy numbers in the left liver lobe [left vs. right lobes for alpha-, beta-, and gamma-fibrinogen (x10(6) copies/ng total RNA): 8.04 vs. 23.16, P<0.001; 4.74 vs. 13.07, P<0.001; and 4.61 vs. 16.38, P = 0.007, respectively], with a parallel reduction in fibrinogen concentration in the left liver lobe (8.53+/-0.33 vs. 10.41 +/-0.65 arbitrary units, P = 0.014, left and right lobes, respectively). No such effect was observed in offspring of control dams. To investigate the underlying mechanism, glucocorticoid receptor function and mRNA levels were studied, since expression of fibrinogen genes is regulated by glucocorticoid hormones. The binding affinity of the high-affinity glucocorticoid receptor was reduced only in the left liver lobe of the MLP offspring (P = 0.02, left. vs. right), with a parallel reduction in this lobe in glucocorticoid receptor mRNA level (P = 0.006, left vs. right). In conclusion, maternal dietary protein restriction reduces fibrinogen gene expression, fibrinogen protein, and mRNA level and binding affinity of glucocorticoid receptors only in the left liver lobe of the adult offspring.

[1]  C. Sibley,et al.  Placental transporter activity and expression in relation to fetal growth , 1997, Experimental physiology.

[2]  P. Sly,et al.  Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. , 1997, American journal of respiratory and critical care medicine.

[3]  J. Seckl,et al.  Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 b -hydroxysteroid dehydrogenase inhibitor carbenoxolone , 1996, Diabetologia.

[4]  A. Hattersley,et al.  The fetal insulin hypothesis: an alternative explanation of the association of low bir thweight with diabetes and vascular disease , 1999, The Lancet.

[5]  J Golding,et al.  Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. , 1989, BMJ.

[6]  J. Seckl,et al.  Glucocorticoids, feto-placental 11β-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease , 1997, Steroids.

[7]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .

[8]  C. Byrne,et al.  A novel highly reproducible quantitative competitve RT PCR system. , 1997, Journal of molecular biology.

[9]  J. Gustafsson,et al.  The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. , 1989, The Journal of biological chemistry.

[10]  J. Seckl.  Glucocorticoids and small babies. , 1994, The Quarterly journal of medicine.

[11]  C Osmond,et al.  Fetal and infant growth and impaired glucose tolerance at age 64. , 1991, BMJ.

[12]  L. M. Berry,et al.  Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. , 1998, American journal of obstetrics and gynecology.

[13]  V. Nguyen.  Fibrinogen and risk of cardiovascular disease: Kannel WB, Wolf PA, Castelli WP, et al JAMA 258: 1183–1186 Sep 1987 , 1988 .

[14]  P. Yudkin,et al.  Influence of maternal nutrition on outcome of pregnancy: prospective cohort study , 1999, BMJ.

[15]  R. Chirino,et al.  Steroid induction of low-affinity glucocorticoid binding sites in rat liver microsomes. , 1989, Journal of steroid biochemistry.

[16]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[17]  R. Benediktsson,et al.  Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. , 1996, Placenta.

[18]  R. D'Agostino,et al.  Fibrinogen and risk of cardiovascular disease. The Framingham Study. , 1987, JAMA.

[19]  C. Martyn,et al.  Plasma concentrations of fibrinogen and factor VII in adult life and their relation to intra‐uterine growth , 1995, British journal of haematology.

[20]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[21]  C. Martyn,et al.  Fetal growth and hyperinsulinaemia in adult life , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[22]  D. Ubben,et al.  Fibrinogen as a major risk factor in cardiovascular disease. , 1990, Trends in pharmacological sciences.

[23]  P. Gluckman,et al.  Fetal nutrition and cardiovascular disease in adult life , 1993, The Lancet.

[24]  M. Ando,et al.  In Situ Morphology of the Ductus Venosus and Related Vessels in the Fetal and Neonatal Rat , 1992, Pediatric Research.

[25]  C. N. Hales,et al.  Non-insulin-dependent diabetes mellitus. , 1997, British medical bulletin.

[26]  M. Nyirenda,et al.  Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. , 1998, The Journal of clinical investigation.

[27]  L. Holland,et al.  Coordinate transcriptional regulation of the three fibrinogen subunit genes by glucocorticoids in cultured primary liver cells from Xenopus laevis. , 1993, Endocrinology.

[28]  K. Yamamoto,et al.  Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA , 1986, Cell.

[29]  D. Barker.  Maternal nutrition, fetal nutrition, and disease in later life. , 1997, Nutrition.

[30]  S. Ceccatelli,et al.  Prenatal Dexamethasone Causes Oligonephronia, Sodium Retention, and Higher Blood Pressure in the Offspring , 1998, Pediatric Research.

[31]  R. Benediktsson,et al.  Placental 11β‐hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure , 1997 .

[32]  B. Walker,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Elevated Plasma Cortisol Concentrations: A Link between Low Birth Weight and the Insulin Resistance Syndrome?* , 2022 .

[33]  J. Grudzinskas,et al.  Placental Function Studies in Low Birth Weight Infants With and Without Dysmaturity , 1985, Obstetrics and gynecology.

[34]  J. Malley,et al.  Evolution and structure of the fibrinogen genes. Random insertion of introns or selective loss? , 1985, Journal of molecular biology.

[35]  Sian Ellard,et al.  Mutations in the glucokinase gene of the fetus result in reduced birth weight , 1998, Nature Genetics.

[36]  A. Caufriez,et al.  Regulation of maternal insulin-like growth factor I by placental growth hormone in pregnancy. Possible action of maternal IGF-I on fetal growth. , 1994, Hormone research.

[37]  M. Woodward,et al.  Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. , 1993, British heart journal.

[38]  C. Byrne,et al.  Differential priming of RNA templates during cDNA synthesis markedly affects both accuracy and reproducibility of quantitative competitive reverse-transcriptase PCR. , 1999, The Biochemical journal.

[39]  D. Barker,et al.  Intrauterine programming of coronary heart disease and stroke , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[40]  G. Duvel.  The study group. , 1980 .

[41]  N. Gilula,et al.  Cloning and characterization of a cDNA for the B beta chain of rat fibrinogen: evolutionary conservation of translated and 3'-untranslated sequences. , 1989, Gene.

[42]  ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. , 1993, European heart journal.

[43]  C. Martyn,et al.  Growth in utero and serum cholesterol concentrations in adult life. , 1993, BMJ.

[44]  G. Targett.  Malaria—variety is the price of life , 1998, Nature Medicine.

[45]  K. Yamamoto,et al.  Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. , 1987, Molecular endocrinology.

[46]  L. Berstein,et al.  WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASE , 1989, The Lancet.

[47]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[48]  Clive Osmond,et al.  Fetal and placental size and risk of hypertension in adult life. , 1990, BMJ.

[49]  D. Barker,et al.  Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. , 1992, BMJ.

[50]  C Osmond,et al.  The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. , 1993, BMJ.

[51]  A. Lucas,et al.  Nutrition in pregnant or lactating rats programs lipid metabolism in the offspring , 1996, British Journal of Nutrition.

[52]  A. Lucas,et al.  Organ-selective growth in the offspring of protein-restricted mothers , 1996, British Journal of Nutrition.

[53]  C. Kessenich,et al.  Diagnosis and management of hypothyroidism in pregnancy. , 1998, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[54]  C. Hales,et al.  ROLE OF FETAL AND INFANT GROWTH IN PROGRAMMING METABOLISM IN LATER LIFE , 1997, Biological reviews of the Cambridge Philosophical Society.

[55]  D. I. Edelstone,et al.  Liver and Ductus Venosus Blood Flows in Fetal Lambs in Utero , 1978, Circulation research.

[56]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[57]  L. Breimer,et al.  Fibrinogen as a cardiovascular risk factor. , 1997, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[58]  S. Ozanne,et al.  Two variants of quantitative reverse transcriptase PCR used to show differential expression of alpha-, beta- and gamma-fibrinogen genes in rat liver lobes. , 1997, The Biochemical journal.